Neutralization of other pro-inflammatory cytokines, such as of TNF-α and IL-17, revealed inconsistent effects on cardiovascular end-points (15) or worsened cardiovascular risk factors as exemplified by the increased risk for hypertension during anti-TNF therapy of rheumatoid arthritis (16). This evidence concerns the gene TNF and hypertensive disorder.